Alternatives to NowPatient

Ark Health is a national direct-to-consumer telehealth platform with one of the widest menus in the directory — compounded semaglutide ($169/mo), tirzepatide ($249/mo) and oral semaglutide ($125/mo).

Marked down on: States served not listed — can't confirm coverage in your state without contacting support

$1,399/mo (brand-name) sema · $1,499/mo (brand-name) tirz

Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

Marked down on: Higher brand-name pricing only

$1,350/mo (brand-name) sema · $1,350/mo (brand-name) tirz

A women's desk that pairs a genuine brand-name Ozempic path with low compounded pricing in all 50 states — every rate of which is a yearly subscription.

Marked down on: No month-to-month price is published anywhere — the $179/mo hero now reads “$179/mo all doses, no hidden fees” and the term has moved into a shared footnote under the treatment cards (“Price calculated based on a yearly subscription plan”), the $149/mo microdose tier carries the same term, and the FAQ quotes a third figure at “starting at just $199 per month (with a 3-month plan)”

$1,299/mo (brand-name) sema · $179/mo (see conditions) tirz

Levity is a telehealth weight loss provider dispensing FDA-approved branded GLP-1 medications only, with no compounded options.

Marked down on: Premium pricing, roughly 1,199 to 1,599 per month

$1,199/mo (brand-name) sema · $1,299/mo (brand-name) tirz

FDAWarning letter issued to Levity Inc. dba Levity in February 2026. See the FDA warning-letter database.

Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss.

Marked down on: Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI